ADME-AP: a database of ADME associated proteins
暂无分享,去创建一个
[1] A. Beresford,et al. ADME/PK as part of a rational approach to drug discovery. , 2000, Drug discovery today.
[2] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[3] J. Caldwell,et al. An Introduction to Drug Disposition: The Basic Principles of Absorption, Distribution, Metabolism, and Excretion , 1995, Toxicologic pathology.
[4] D. Roden,et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.
[5] K. Giacomini,et al. Role of organic cation transporters in drug absorption and elimination. , 1998, Annual review of pharmacology and toxicology.
[6] Pickett,et al. Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.
[7] H. Halsall,et al. Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. , 1992, The Biochemical journal.
[8] M. Green,et al. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. , 1994, Drug metabolism and disposition: the biological fate of chemicals.
[9] P J Sinko,et al. Development of predictive pharmacokinetic simulation models for drug discovery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.